 |
Recombinant human platelet derived growth factor BB |
|---|---|
| Trade Name | |
| Orphan Indication | Osteonecrosis |
| USA Market Approval | USA |
| USA Designation Date | 2007-02-01 00:00:00 |
| Sponsor | Luitpold Pharmaceuticals, Inc.;800 Adams Avenue, Suite 100;Norristown, Pennsylvania, 19403 |
